Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Debt (2020 - 2025)

Oncology Institute (TOI) has disclosed Total Debt for 6 consecutive years, with $76.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Debt fell 16.76% year-over-year to $76.2 million, compared with a TTM value of $76.2 million through Sep 2025, down 16.76%, and an annual FY2024 reading of $93.1 million, up 7.26% over the prior year.
  • Total Debt was $76.2 million for Q3 2025 at Oncology Institute, up from $75.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $93.1 million in Q4 2024 and bottomed at $183000.0 in Q4 2021.
  • Average Total Debt over 5 years is $77.6 million, with a median of $82.9 million recorded in 2023.
  • The sharpest move saw Total Debt tumbled 98.47% in 2021, then skyrocketed 43955.19% in 2022.
  • Year by year, Total Debt stood at $183000.0 in 2021, then surged by 43955.19% to $80.6 million in 2022, then grew by 7.7% to $86.8 million in 2023, then rose by 7.26% to $93.1 million in 2024, then dropped by 18.19% to $76.2 million in 2025.
  • Business Quant data shows Total Debt for TOI at $76.2 million in Q3 2025, $75.0 million in Q2 2025, and $73.9 million in Q1 2025.